JAZZ PHARMACEUTICALS. TRANSFORMING LIVES. REDEFINING POSSIBILITIES.
DEAD

Serial Number

97158188

Owner

Jazz Pharmaceuticals, Inc.

Attorney

Timothy D. Sitzmann

Filing Date

Dec 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

JAZZ PHARMACEUTICALS. TRANSFORMING LIVES. REDEFINING POSSIBILITIES. Trademark

Serial Number: 97158188

JAZZ PHARMACEUTICALS. TRANSFORMING LIVES. REDEFINING POSSIBILITIES. is a trademark filed by Jazz Pharmaceuticals, Inc. on December 6, 2021. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Jazz Pharmaceuticals, Inc. (125 trademarks)

3170 PORTER DRIVE
PALO ALTO, CA 94304

Entity Type: 03

Trademark Details

Filing Date

December 6, 2021

Registration Date

Not Registered

Published for Opposition

November 1, 2022

Goods & Services

Providing medical information; providing medical information regarding treatment and management of diseases, disorders, and conditions, including in the fields of sleep, hematology, neurologic disorders, central nervous system disorders, psychiatric disorders, neuropsychiatry, psychiatric disorders, and oncology

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 31, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 31, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 20, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2021 NWOS
NEW APPLICATION ENTERED
Dec 9, 2021 NWAP